21 research outputs found

    A successful pregnancy outcome in a testicular cancer survivor: case report

    Get PDF
    Testicular cancer is the most common cancer in young men. We report a successful pregnancy that was achieved by intracytoplasmic sperm injection (ICSI) using cryopreserved semen from a man with testicular cancer. He was treated for left testicular mixed germ cell tumor with left radical orchiectomy followed by chemotherapy. Three years post chemotherapy, the couple had two successive failures of intrauterine insemination (IUI) with cryopreserved semen. The couple then underwent Assisted reproduction with ICSI. Ten oocytes were retrieved following stimulation of which six oocytes fertilized and progressed. She had transfer of two healthy embryos and the remaining four embryos cryopreserved. Singleton pregnancy was achieved and she delivered a healthy girl baby at 38 weeks of gestation. Assisted reproduction with ICSI is a boon to the male patients with cancer and offers them a chance of fathering their own biological offspring

    The NIH-NIAID Schistosomiasis Resource Center

    Get PDF
    A bench scientist studying schistosomiasis must make a large commitment to maintain the parasite's life cycle, which necessarily involves a mammalian (definitive) host and the appropriate species of snail (intermediate host). This is often a difficult and expensive commitment to make, especially in the face of ever-tightening funds for tropical disease research. In addition to funding concerns, investigators usually face additional problems in the allocation of sufficient lab space to this effort (especially for snail rearing) and the limited availability of personnel experienced with life cycle upkeep. These problems can be especially daunting for the new investigator entering the field. Over 40 years ago, the National Institutes of Health–National Institute of Allergy and Infectious Diseases (NIH-NIAID) had the foresight to establish a resource from which investigators could obtain various schistosome life stages without having to expend the effort and funds necessary to maintain the entire life cycle on their own. This centralized resource translated into cost savings to both NIH-NIAID and to principal investigators by freeing up personnel costs on grants and allowing investigators to divert more funds to targeted research goals. Many investigators, especially those new to the field of tropical medicine, are only vaguely, if at all, aware of the scope of materials and support provided by this resource. This review is intended to help remedy that situation. Following a short history of the contract, we will give a brief description of the schistosome species provided, provide an estimate of the impact the resource has had on the research community, and describe some new additions and potential benefits the resource center might have for the ever-changing research interests of investigators

    AgNPs doped TEOS sol–gel coatings to prevent the adhesion of marine fouling organisms

    Full text link
    Biosynthesis of silver nanoparticles (AgNPs) using plants is considered to be cost effective and more eco‐friendly than conventional techniques. In the authors’ previous study, they reported the biosynthesis of AgNPs using fruit extract of Aegle marmelos which were of spherical shape and high crystallinity. In order to achieve enhanced synthesis, optimisation of process parameters influencing the yield of AgNPs has been carried out in this study. Box–Behnken design has been employed to optimise the parameters in order to enhance the synthesis of AgNPs. The antimicrofouling activity of the optimised AgNPs was determined by preparing AgNPs doped TEOS sol–gels (SNSGs) and evaluating their antibiofilm activity. In addition to this, antimacrofouling activity of the AgNPs was studied against molluscs viz. Patella sp. and Trochus sp. as model organisms. Anticrustacean assay was also performed with the larvae of brine shrimp (Artemia salina) as a model crustacean fouling organism. The results indicated that the AgNPs could completely inhibit the attachment of molluscs and significantly increased the percentage of mortality against crustacean fouling larvae. Thus, this study gives scope for the possible development of formulations containing AgNPs as effective antifouling agents that could prevent the adhesion of micro and macrofoulers thereby preventing marine biofouling

    Biosynthesis of Silver Nanoparticles Using Aegle marmelos (Bael) Fruit Extract and Its Application to Prevent Adhesion of Bacteria: A Strategy to Control Microfouling

    Get PDF
    Marine biofilms formed due to adhesion of bacteria and other microorganisms on submerged surfaces are generally considered to be a major form of microfouling. Subsequent attachment of larvae of higher organisms like barnacles, mussels, and so forth, on marine biofilms, causes macrofouling. Several approaches have been used to prevent micro- and macrofouling. Silver nanoparticles (AgNPs) are known to exhibit strong inhibitory and antimicrobial activity. Biological synthesis of AgNPs is rapidly gaining importance due to its growing success. Hence, the present study is focused on the biosynthesis of AgNPs using fruit extract of Aegle marmelos and its characterization through UV-Vis spectrophotometer, X-ray diffractometer (XRD), Fourier transform infrared spectroscopy (FTIR), and atomic force microscopy (AFM). Further isolation and identification of marine biofilm forming bacteria were carried out through 16S rDNA analysis. The antimicrofouling effect of the biosynthesized AgNPs was tested against marine biofilm forming bacteria and the results suggested that it could effectively inhibit biofilm formation. This preliminary study has proved that AgNPs may be used as antimicrofouling agent for the prevention of biofouling in the early stages

    The Geographic Location of Recipient Laboratories of Snails and/or Mammals Provided by the NIH-NIAID Schistosomiasis Resource Center.

    No full text
    <p>The Geographic Location of Recipient Laboratories of Snails and/or Mammals Provided by the NIH-NIAID Schistosomiasis Resource Center.</p
    corecore